PTC Therapeutics
PTCT
#2848
Rank
โ‚ฌ4.81 B
Marketcap
58,19ย โ‚ฌ
Share price
0.55%
Change (1 day)
11.56%
Change (1 year)

Revenue for PTC Therapeutics (PTCT)

Revenue in 2025 (TTM): โ‚ฌ1.55 Billion

According to PTC Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.50 Billion. an increase over the revenue in the year 2024 that were of โ‚ฌ0.77 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PTC Therapeutics from 2012 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ1.47 B90.02%
2024 โ‚ฌ0.77 B-8.61%
2023 โ‚ฌ0.84 B30.22%
2022 โ‚ฌ0.65 B36.98%
2021 โ‚ฌ0.47 B53.63%
2020 โ‚ฌ0.30 B12.97%
2019 โ‚ฌ0.27 B18.42%
2018 โ‚ฌ0.23 B42.84%
2017 โ‚ฌ0.16 B106.05%
2016 โ‚ฌ78.62 M119.04%
2015 โ‚ฌ35.89 M90.11%
2014 โ‚ฌ18.88 M-16.76%
2013 โ‚ฌ22.68 M4.26%
2012 โ‚ฌ21.75 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚ฌ49.13 B 3,174.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚ฌ10.40 B 593.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.14 B-90.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.09 B 39.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚ฌ6.18 M-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚ฌ16.26 M-98.92%๐Ÿ‡บ๐Ÿ‡ธ USA